Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Other Non-Current Assets (2020 - 2025)

Historic Other Non-Current Assets for Silo Pharma (SILO) over the last 7 years, with Q2 2025 value amounting to $56226.0.

  • Silo Pharma's Other Non-Current Assets fell 940.64% to $56226.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $56226.0, marking a year-over-year decrease of 940.64%. This contributed to the annual value of $59145.0 for FY2024, which is 898.39% down from last year.
  • According to the latest figures from Q2 2025, Silo Pharma's Other Non-Current Assets is $56226.0, which was down 940.64% from $57685.0 recorded in Q1 2025.
  • In the past 5 years, Silo Pharma's Other Non-Current Assets ranged from a high of $72285.0 in Q3 2022 and a low of $19375.0 during Q1 2021
  • In the last 5 years, Silo Pharma's Other Non-Current Assets had a median value of $62229.0 in 2022 and averaged $57368.7.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first crashed by 2038.29% in 2021, then surged by 22203.35% in 2022.
  • Over the past 5 years, Silo Pharma's Other Non-Current Assets (Quarter) stood at $26659.0 in 2021, then skyrocketed by 165.66% to $70821.0 in 2022, then dropped by 8.24% to $64983.0 in 2023, then dropped by 8.98% to $59145.0 in 2024, then fell by 4.94% to $56226.0 in 2025.
  • Its Other Non-Current Assets was $56226.0 in Q2 2025, compared to $57685.0 in Q1 2025 and $59145.0 in Q4 2024.